Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exagen Inc. - Common Stock
(NQ:
XGN
)
7.390
-0.130 (-1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exagen Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Exagen (XGN) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Record revenue and near break-even adjusted EBITDA signal progress toward profitability.
Via
The Motley Fool
Topics
Earnings
Economy
Exagen Q2 Earnings Call Highlights
↗
August 04, 2026
Exagen (NASDAQ:XGN) reported record second-quarter revenue as growth in AVISE CTD test volume, average selling price and Pharma Services revenue brought the autoimmune diagnostics company close to...
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 04, 2026
Via
Chartmill
Exagen (NASDAQ:XGN) Beats Q2 Estimates and Raises Full-Year Guidance
↗
August 04, 2026
Via
Chartmill
Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally
↗
May 11, 2026
Via
Chartmill
Topics
Earnings
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook
↗
March 10, 2026
Via
Chartmill
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Exagen Stock
↗
September 11, 2025
Via
Benzinga
Top movers in Tuesday's session
↗
August 04, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
August 04, 2026
Via
Chartmill
Tuesday's pre-market session: top gainers and losers
↗
August 04, 2026
Via
Chartmill
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 04, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conference
July 28, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Second Quarter Financial Results on August 4, 2026
July 21, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 01, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen (XGN) Q1 2026 Earnings Transcript
↗
May 12, 2026
Exagen (XGN) Q1 2026 Earnings Transcript
Via
The Motley Fool
Exagen Q1 Earnings Call Highlights
↗
May 11, 2026
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician...
Via
MarketBeat
Topics
Earnings
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
Delivers record total revenue and AVISE(R) CTD average selling price
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
April 27, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
March 10, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conferences
March 03, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
February 24, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Select Preliminary 2025 Financial Results
January 11, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 11, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss
↗
November 04, 2025
Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline.
Via
Chartmill
Exagen Inc. Reports Strong Q3 2025 Results
November 04, 2025
From
Exagen Inc.
Via
GlobeNewswire
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
↗
October 27, 2025
Via
Benzinga
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
October 23, 2025
From
Exagen Inc.
Via
GlobeNewswire
Demystifying Exagen: Insights From 5 Analyst Reviews
↗
October 22, 2025
Via
Benzinga
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From
Exagen Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
